However, the MLE for CD8α and FoxP3 is consistently lower (ranging from 30 to 50%) in the 4T1 tumor model relative to CT26 tumor model, where MLE is > 70% (see Supplementary Table 4 for summary table). This evidence concerns the gene CD8A and neoplasm.